Failure to Assess Skin Changes and Administer Ordered Medications
Summary
The facility failed to ensure that skin discolorations were assessed and monitored for Resident 10, who had diagnoses including atrial fibrillation, hypertension, and dementia and was cognitively impaired with partial moderate assistance needs for bed mobility, transfers, and walking. Purple discolorations were observed on the tops of both hands, and later additional scabbed areas and a discoloration on the left forearm were seen. A weekly skin assessment dated 12/15/25 indicated no skin alterations, including bruising, and the wound care nurse stated she was unaware of the discolorations and that they had not been assessed or monitored. The facility policy required direct care staff to report skin alterations, including bruises, to a licensed nurse for further assessment. The facility also failed to administer calcitriol as ordered for Resident 8, who had hypertension, end stage renal disease, and obstructive uropathy and received dialysis services. The physician ordered calcitriol 0.25 mcg daily for end stage renal disease, but the November 2025 MAR showed multiple missed administrations because the drug item was not available or was waiting on arrival. The DON stated the medication was in the emergency drug kit and staff could have obtained it from there while waiting for pharmacy delivery. For Resident 3, who had type 2 diabetes mellitus and severe cognitive impairment, the MAR showed several missed administrations of insulin lispro and insulin glargine despite physician orders for insulin lispro four times daily per sliding scale and insulin glargine 20 units daily. The care plan identified the resident as at risk for adverse effects of hyperglycemia or hypoglycemia and included interventions to provide medications as ordered and monitor blood sugars as ordered. The DON stated nurses ran EMAR compliance checks and reported no missed medications, but had no further information. For Resident 18, who had lung and bone cancer and was cognitively intact, the MAR showed missed administrations of buspirone, lactulose, ipratropium-albuterol nebulizer treatments, oxycodone, and lidocaine cream despite active physician orders for each medication, and the DON again had no further information to provide.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.